Karyopharm therapeutics inc. (KPTI)
Balance Sheet / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Dec'12
Assets
Current assets:
Cash and cash equivalents

202,247

128,858

168,004

75,545

83,506

118,021

101,600

118,966

37,499

68,997

54,450

55,381

25,577

49,663

43,908

37,717

42,188

58,358

43,499

24,231

51,453

150,609

227,131

132,307

144,893

155,974

52,928

391

Short-term investments

149,884

133,098

99,525

141,614

180,918

210,178

105,170

122,155

93,418

77,472

64,956

88,073

84,307

79,889

82,903

85,019

94,228

117,275

151,738

196,955

194,956

55,115

-

-

-

-

-

-

Accounts receivable

9,300

7,900

7,928

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Inventory

970

346

100

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Prepaid expenses and other current assets

7,551

7,289

5,310

5,671

7,011

6,413

4,792

3,438

2,396

1,754

2,076

2,070

2,146

2,084

3,440

1,464

1,726

1,967

3,107

4,066

2,910

2,027

4,215

2,976

2,673

1,982

658

563

Restricted cash

987

1,117

-

-

-

-

-

-

-

200

200

200

200

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total current assets

370,920

278,570

280,867

222,830

271,435

334,612

211,562

244,559

133,313

148,423

121,682

145,724

112,230

131,636

130,251

124,200

138,142

177,600

198,344

225,252

249,319

207,751

231,346

135,283

147,566

157,956

53,586

954

Property and equipment, net

2,814

3,046

3,240

3,375

3,617

3,863

2,914

2,611

2,454

2,185

2,304

2,473

2,654

2,836

2,991

3,170

3,343

3,483

3,660

3,234

3,282

2,754

2,734

604

322

240

246

327

Operating lease right-of-use assets

10,320

10,617

10,904

11,180

11,448

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Long-term investments

31,373

2,016

2,022

-

-

2,001

4,804

8,781

10,314

29,396

39,498

37,269

40,257

45,434

49,598

42,933

50,165

33,878

34,430

34,407

38,539

8,658

-

-

-

-

-

-

Restricted cash

714

714

712

715

714

716

712

638

292

290

289

284

279

479

484

483

485

482

485

400

400

400

400

400

400

-

-

-

Other assets

-

-

-

-

-

-

-

-

-

-

-

-

15

-

299

111

-

-

52

-

500

774

675

1,392

997

30

2,072

30

Total assets

416,141

294,963

297,745

238,100

287,214

341,192

219,992

256,589

146,373

180,294

163,773

185,750

155,435

180,385

183,623

170,897

192,135

215,443

236,971

263,293

292,040

220,337

235,155

137,679

149,285

158,226

55,904

1,311

Liabilities and stockholders' equity
Current liabilities:
Accounts payable

1,694

985

3,068

1,113

2,266

4,332

2,238

3,794

4,949

5,665

1,890

3,247

4,245

4,751

2,193

4,063

4,109

3,808

4,568

4,469

6,957

6,288

2,102

3,456

3,273

1,740

1,749

1,076

Accrued expenses

43,783

40,878

32,421

27,799

28,868

32,493

29,155

22,969

21,545

21,445

17,715

12,876

10,740

11,362

12,309

11,112

8,652

11,023

9,469

9,333

7,417

5,825

3,649

2,003

1,550

1,168

1,920

764

Deferred revenue

1,287

2,341

1,053

1,287

10,650

9,362

9,362

9,363

19,729

21,921

1,050

1,025

-

-

-

-

-

-

-

-

-

-

14

36

57

79

-

66

Operating lease liabilities

1,711

1,646

1,583

1,522

1,375

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred rent

-

-

-

-

-

390

256

189

178

303

298

292

286

280

275

269

263

206

200

200

200

126

142

22

-

-

-

-

Other current liabilities

1,224

500

1,077

453

701

327

556

229

333

133

202

80

210

83

175

79

198

95

203

97

128

62

327

130

135

305

327

24

Total current liabilities

49,699

46,350

39,202

32,174

43,860

46,904

41,567

36,544

46,734

49,467

21,155

17,520

15,481

16,476

14,952

15,523

13,222

15,132

14,440

14,099

14,702

12,301

6,234

5,647

5,015

3,292

3,996

1,930

Convertible senior notes

111,769

109,857

107,962

106,157

104,368

102,664

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred royalty obligation

73,588

73,588

73,589

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Operating lease liabilities, net of current portion

12,746

13,202

13,643

14,055

14,457

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue, net of current portion

2,192

2,192

3,479

3,245

3,245

4,532

4,532

4,532

2,192

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred rent, net of current portion

-

-

-

-

-

3,922

2,815

2,041

1,918

1,363

1,441

1,516

1,591

1,666

1,739

1,808

1,877

1,946

1,939

1,867

1,813

1,242

1,117

201

-

-

-

-

Other long-term liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

151

170

-

-

-

Total liabilities

249,994

245,189

237,875

155,631

165,930

158,022

48,914

43,117

50,844

50,830

22,596

19,036

17,072

18,142

16,691

17,331

15,099

17,078

16,379

15,966

16,515

13,543

7,351

5,999

-

3,292

-

-

Commitments and contingencies (Note 9)

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

0

-

-

-

0

-

-

-

0

0

0

Preferred stock subscription

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

8,980

Convertible preferred stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

18,278

Total convertible preferred stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

27,258

Stockholders' equity:
Preferred stock, $0.0001 par value; 5,000 shares authorized; none issued and outstanding

-

-

-

-

-

-

0

0

0

-

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

-

0

Common stock, $0.0001 par value; 200,000 shares authorized; 73,095 and 65,370 shares issued and outstanding at March 31, 2020 and December 31, 2019, respectively

7

7

6

6

6

6

6

6

5

5

5

5

4

4

4

4

4

4

4

4

4

3

3

3

3

3

0

-

Additional paid-in capital

1,092,829

923,142

884,585

865,726

861,215

857,156

786,763

781,180

629,610

625,017

597,562

592,534

534,838

528,617

506,125

467,168

460,524

455,170

448,095

444,574

439,914

345,166

340,219

224,371

220,360

217,500

2,639

745

Accumulated other comprehensive loss

-420

-37

-30

61

-28

-244

-153

-260

-286

-217

-90

-165

-204

-274

-28

138

94

-282

-26

-143

19

-29

-

-

-

-

-

-

Accumulated deficit

-926,269

-873,338

-824,691

-783,324

-739,909

-673,748

-615,538

-567,454

-533,800

-495,341

-456,300

-425,660

-396,275

-366,104

-339,169

-313,744

-283,586

-256,527

-227,481

-197,108

-164,412

-138,346

112,418

92,694

76,263

-62,569

50,423

28,622

Total stockholders' equity

166,147

49,774

59,870

82,469

121,284

183,170

171,078

213,472

95,529

129,464

141,177

166,714

138,363

162,243

166,932

153,566

177,036

198,365

220,592

247,327

275,525

206,794

227,804

131,680

144,100

154,934

-47,784

-27,877

Total liabilities and stockholders' equity

416,141

294,963

297,745

238,100

287,214

341,192

219,992

256,589

146,373

180,294

163,773

185,750

155,435

180,385

183,623

170,897

192,135

215,443

236,971

263,293

292,040

220,337

235,155

137,679

149,285

158,226

55,904

1,311